Skip to main content
. 2020 Jun 17;15(6):e0233840. doi: 10.1371/journal.pone.0233840

Table 3. Summary of post-immunization laboratory abnormalities by parameter and grade for subjects in both cohorts by true and mock groups over all five immunizations.

Cohort 1 Cohort 2
True Immunized N = 13 Mock Immunized N = 4 True Immunized N = 12 Mock Immunized N = 4
Lab test (units) Grade 1 n (%) Grade 2 n (%) Grade 1 n (%) Grade 2 n (%) Grade 1 n (%) Grade 2 n (%) Grade 1 n (%) Grade 2 n (%)
Any immunization
    ALP (U/L) 1 (7.7) 0 1 (25) 0 0 0 0 0
    ALT (U/L) 6 (46.2) 0 2 (50) 1 (25) 4 (33.3) 1 (8.3) 1 (25) 0
    AST (U/L) 3 (23.1) 2 (15.4) 1 (25) 1 (25) 3 (25) 1 (8.3) 0 0
    BUN (mg/dL) 4 (30.8) 2 (50) 2 (50) 0 1 (8.3) 0 2 (50) 0
    Creatinine (mg/dL) 3 (23.1) 1 (7.7) 2 (50) 0 3 (25) 0 2 (50) 0
    Eosinophils (cells/uL) 1 (7.7) 1 (7.7) 0 0 2 (16.7) 0 0 0
    Hemoglobin (g/dL) 0 3 (23.1) 2 (50) 0 0 0 0 0
    Lymphocytes (cells/uL) 3 (23.1) 3 (23.1) 1 (25) 3 (75) 2 (16.7) 0 0 0
    Neutrophils (cells/uL) 3 (23.1) 2 (15.4) 1 (25) 1 (25) 0 0 0 0
    Platelets (10x3/uL) 1 (7.7) 2 (15.4) 1 (25) 0 0 0 0 0
    Total bilirubin (mg/dL) 2 (15.4) 0 0 0 1 (8.3) 0 0 0
    WBC (10x3/uL) 5 (38.5) 1 (7.7) 1 (25) 1 (25) 3 (25) 0 0 0

Column header counts and denominators are the number of subjects who received at least one immunization.

Subjects with at least one abnormal lab within 7 days of any immunization are presented.

A subject is counted once per row.

No Grade 3 or 4 severity lab abnormalities were reported.